Small cell lung cancer: Current status of new chemotherapeutic agents

Martin J. Edelman; David R. Gandara

doi:10.1016/S1040-8428(98)00002-X

Small cell lung cancer: Current status of new chemotherapeutic agents

Martin J. Edelman
, David R. Gandara

U.S. Department of Veterans Affairs
University of California at Davis

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Original language	English
Pages (from-to)	211-220
Number of pages	10
Journal	Critical Reviews in Oncology/Hematology
Volume	27
Issue number	3
DOIs	https://doi.org/10.1016/S1040-8428(98)00002-X
State	Published - Apr 1 1998

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Antineoplastic Agents/therapeutic use
Carcinoma, Small Cell/drug therapy
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Combined Modality Therapy
Humans
Lung Neoplasms/drug therapy
Multicenter Studies as Topic

Access to Document

10.1016/S1040-8428(98)00002-X

Cite this

@article{6ae7436791f14d389f5089430e855c84,

title = "Small cell lung cancer: Current status of new chemotherapeutic agents",

keywords = "Antineoplastic Agents/therapeutic use, Carcinoma, Small Cell/drug therapy, Clinical Trials, Phase II as Topic, Clinical Trials, Phase III as Topic, Combined Modality Therapy, Humans, Lung Neoplasms/drug therapy, Multicenter Studies as Topic",

author = "Edelman, \{Martin J.\} and Gandara, \{David R.\}",

year = "1998",

month = apr,

day = "1",

doi = "10.1016/S1040-8428(98)00002-X",

language = "English",

volume = "27",

pages = "211--220",

journal = "Critical Reviews in Oncology/Hematology",

issn = "1040-8428",

publisher = "Elsevier Ireland Ltd",

number = "3",

}

TY - JOUR

T1 - Small cell lung cancer

T2 - Current status of new chemotherapeutic agents

AU - Edelman, Martin J.

AU - Gandara, David R.

PY - 1998/4/1

Y1 - 1998/4/1

KW - Antineoplastic Agents/therapeutic use

KW - Carcinoma, Small Cell/drug therapy

KW - Clinical Trials, Phase II as Topic

KW - Clinical Trials, Phase III as Topic

KW - Combined Modality Therapy

KW - Humans

KW - Lung Neoplasms/drug therapy

KW - Multicenter Studies as Topic

UR - https://www.scopus.com/pages/publications/0032052595

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000074080400003&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1016/S1040-8428(98)00002-X

DO - 10.1016/S1040-8428(98)00002-X

M3 - Article

C2 - 9649933

SN - 1040-8428

VL - 27

SP - 211

EP - 220

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

IS - 3

ER -

Small cell lung cancer: Current status of new chemotherapeutic agents

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this